ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

IGX Intelgenx Technologies Corp

0,24
0,00 (0,00%)
Última atualização: 10:45:00
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Intelgenx Technologies Corp IGX Toronto Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,00 0,00% 0,24 10:45:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
0,24
mais cotações »

Notícias Recentes

Data Hora Fonte Título
28/05/202411:05GLOBEIntelGenx Obtains Court-Approval of a Sale and Investment..
17/05/202418:39GLOBEIntelGenx Initiates Restructuring Proceedings Under the CCAA..
17/05/202411:04GLOBEIntelGenx Initiates Restructuring Proceedings Under the CCAA..
17/05/202410:18PRNCASuspension de la négociation par l'Organisme canadien de..
17/05/202410:13PRNCACanadian Investment Regulatory Organization Trading Halt -..
08/05/202408:45GLOBEIntelGenx Announces Voting Results on Election of Directors
08/04/202408:45GLOBEIntelGenx Announces First Parkinson’s Disease Patients Dosed..
05/04/202408:45GLOBEIntelGenx Updates Status of Buprenorphine Buccal Film ANDA
21/03/202408:30GLOBEIntelGenx Reports Fourth Quarter and Full-Year 2023..
14/03/202417:30GLOBEIntelGenx to Report Fourth Quarter and Full Year 2023..
11/03/202408:45GLOBEIntelGenx Enters Into a Third Amended and Restated Loan..
20/02/202412:50GLOBEUPDATE -- IntelGenx Launches Preferred Share Regulation A..
20/02/202409:50GLOBEIntelGenx Launches Preferred Share Regulation A Offering
05/02/202410:00GLOBEStudies Validate Advantages of Administering Drugs to Pets..
18/12/202309:15GLOBEIntelGenx Announces New Animal Health Partnership; Enters..
05/12/202310:00GLOBEIntelGenx Announces Closing of Previously Announced..
04/12/202310:00GLOBEIntelGenx Announces Changes to its Board of Directors
28/11/202318:05GLOBEIntelGenx Announces Shareholder Approval of Financing..
14/11/202309:30GLOBEIntelGenx Receives Approval to Conduct ’MONTPARK’..
13/11/202310:00GLOBEIntelGenx Reminds Shareholders to Vote at Upcoming Special..
09/11/202318:05GLOBEIntelGenx Reports Third Quarter 2023 Financial Results
06/11/202310:30GLOBEIntelGenx Announces Co-development and Commercialization of..
02/11/202317:45GLOBEIntelGenx to Report Third Quarter 2023 Financial Results on..
21/09/202309:00GLOBEIntelGenx Provides RIZAFILM® U.S. Commercialization Update
19/09/202309:00GLOBEIntelGenx Provides Regulatory Update for Xiromed-Partnered..
31/08/202309:30GLOBEIntelGenx Announces Closing of First Tranche of Non-Brokered..
14/08/202317:03GLOBEIntelGenx Reports Second Quarter 2023 Financial Results
10/08/202317:30GLOBEIntelGenx Announces First Agreement for CDMO Packaging..
07/08/202317:30GLOBEIntelGenx to Report Second Quarter 2023 Financial Results on..
01/08/202309:00GLOBEIntelGenx Completes Enrollment for ‘BUENA’ Montelukast..
25/07/202309:00GLOBEIntelGenx Provides Update on Research Collaboration..
21/07/202317:30GLOBEIntelGenx Announces a Change to its Board of Directors
06/07/202317:30GLOBEIntelGenx Announces Voting Results on Election of Directors